Cancer organisations unite to urgently tackle ‘symptom hesitancy’ and testing ‘rollercoaster’ during lockdowns

Pharma News: Cancer organisations across Australia have launched a joint campaign to urgently tackle cancer ‘symptom hesitancy’, a COVID-related health crisis that has seen the number of people coming forward for testing, screening and routine follow-up treatment plummet during the pandemic.

The New Normal Same Cancer: Conversations campaign, supported by AstraZeneca Australia, aims to reduce delays in cancer diagnosis.

COVID-19 has had multiple impacts on the diagnosis and treatment of cancer. Service providers are reporting a ‘rollercoaster effect’ in people coming forward for testing procedures relating to cancer investigations and treatment in response to the pandemic. 

During the first wave of the COVID-19 pandemic in 2020, there were approximately 148,000 fewer diagnostic procedures for breast, colorectal, lung, and prostate cancers compared to the same period in 2019. The decline increased during restrictions and flatten when they are lifted.

Australia’s leading cancer organisations are worried that ongoing lockdowns and changing restrictions are establishing ‘cancer symptom hesitancy’ as the new normal in cancer treatment. They believe this hesitancy to get symptoms checked and attend appointments is one of the biggest challenges facing the entire cancer community.

Featuring hard-hitting real life stories, the new conversations campaign has received official support from the Chief Executive of Cancer Australia, Professor Dorothy Keefe, who has a simple message for anyone experiencing unusual or persistent symptoms: Don’t wait. Contact your doctor. Get checked.

Professor Keefe stated “It’s natural to think, if we have a new symptom, that it will probably clear up on its own. We tend to think that these things can wait. But unfortunately, cancer won’t wait. Most symptoms are due to something less serious than cancer but, if it is cancer, the earlier it is found the better.”

Mark Brooke, Chief Executive of the Lung Foundation, said “New Normal Same Cancer: Conversations will resonate with all of us. It’s all too easy to play down our own health needs because, in our COVID-19 impacted lives, there always seem more important things to deal with. But, as this campaign shows, if you have unusual or persistent symptoms, having a conversation with your GP needs to be a priority, whatever your age.”

Sharon Millman, Chief Executive of Lymphoma Australia, commented “This powerful campaign is vital if we are to help more Australians diagnose their cancer at the earliest opportunity. If you have a persistent symptom, please don’t wait for COVID-19 to end before seeing your doctor. Because cancer won’t wait.”

Compared to the same period in 2019, between January-September 2020, there were:  

• 16,694 fewer diagnostic procedures and 1,109 fewer surgical procedures for breast cancer
• 78,048 fewer diagnostic and 381 fewer surgical procedures for colorectal cancer
• 961 fewer diagnostic and 180 more surgical procedures for lung cancer
• 52,471 tests fewer diagnostic and 305 fewer surgical procedures for prostate cancer
• 34,268 fewer non-surgical and surgical procedures for skin cancers other than melanomas and melanoma skin cancers

The cancer organisations who have joined the New Normal Same Cancer campaign are; Cancer Australia, Bowel Cancer Australia, GI Cancer Institute, Leukaemia Foundation, Lymphoma Australia, Lung Foundation Australia, Neuroendocrine Cancer Australia, Ovarian Cancer Australia, Pancare Foundation, Pankind, Pink Hope, Prostate Cancer Australia, Rare Cancers Australia, and So Brave.